For example, JNJ-42756493, a potent inhibitor of the tyrosine kinase activities of the four FGFR family members, may be beneficial for treating gastric cancer with FGFR2 amplification and those that harbour the G636C-FGFR4 mutation37. The gene discussed is FGFR2; the disease is gastric cancer.